Variant report

Variant	nsv428712
Chromosome Location	chrX:110184832-110358638
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chrX:110358073-110358405	GM12878	blood:	n/a	n/a
2	BACH1	chrX:110188424-110188545	H1-hESC	embryonic stem cell:	n/a	n/a
3	BCL3	chrX:110349210-110349641	GM12878	blood:	n/a	n/a
4	BCL3	chrX:110349264-110349860	GM12878	blood:	n/a	n/a
5	BHLHE40	chrX:110210118-110210657	HepG2	liver:	n/a	chrX:110210564-110210573 chrX:110210559-110210580
6	BHLHE40	chrX:110210602-110210630	GM12878	blood:	n/a	n/a
7	BHLHE40	chrX:110343412-110343498	GM12878	blood:	n/a	n/a
8	CEBPB	chrX:110210042-110210408	HepG2	liver:	n/a	chrX:110210204-110210221 chrX:110210207-110210220 chrX:110210207-110210218 chrX:110210209-110210220 chrX:110210207-110210220
9	CEBPB	chrX:110260704-110260939	A549	lung:	n/a	n/a
10	CEBPB	chrX:110242389-110242728	A549	lung:	n/a	chrX:110242565-110242574 chrX:110242563-110242576 chrX:110242565-110242576 chrX:110242565-110242574 chrX:110242563-110242574 chrX:110242565-110242574 chrX:110242565-110242574
11	CEBPB	chrX:110242415-110242727	HepG2	liver:	n/a	chrX:110242565-110242574 chrX:110242563-110242576 chrX:110242565-110242576 chrX:110242565-110242574 chrX:110242563-110242574 chrX:110242565-110242574 chrX:110242565-110242574
12	CEBPB	chrX:110249364-110249723	IMR90	lung:	n/a	n/a
13	CEBPB	chrX:110236332-110236495	K562	blood:	n/a	chrX:110236366-110236377
14	CEBPB	chrX:110353616-110353943	A549	lung:	n/a	chrX:110353752-110353763 chrX:110353821-110353833
15	CEBPB	chrX:110340170-110340457	IMR90	lung:	n/a	chrX:110340278-110340289 chrX:110340277-110340290 chrX:110340277-110340290
16	CEBPB	chrX:110340142-110340374	H1-hESC	embryonic stem cell:	n/a	chrX:110340278-110340289 chrX:110340277-110340290 chrX:110340277-110340290
17	CEBPB	chrX:110249377-110249708	HepG2	liver:	n/a	n/a
18	CEBPB	chrX:110236205-110236508	IMR90	lung:	n/a	chrX:110236366-110236377
19	CEBPB	chrX:110344108-110344320	A549	lung:	n/a	n/a
20	CEBPB	chrX:110249394-110249658	A549	lung:	n/a	n/a
21	CEBPB	chrX:110236236-110236527	HepG2	liver:	n/a	chrX:110236366-110236377
22	CEBPB	chrX:110339200-110339539	IMR90	lung:	n/a	n/a
23	CEBPB	chrX:110319452-110319799	IMR90	lung:	n/a	chrX:110319615-110319626
24	CEBPB	chrX:110339356-110339399	K562	blood:	n/a	n/a
25	CEBPB	chrX:110353392-110353943	Hela-S3	cervix:	n/a	chrX:110353752-110353763 chrX:110353821-110353833
26	CEBPB	chrX:110242431-110242721	IMR90	lung:	n/a	chrX:110242565-110242574 chrX:110242563-110242576 chrX:110242565-110242576 chrX:110242565-110242574 chrX:110242563-110242574 chrX:110242565-110242574 chrX:110242565-110242574
27	CEBPB	chrX:110263567-110263838	H1-hESC	embryonic stem cell:	n/a	chrX:110263706-110263717
28	CEBPB	chrX:110319444-110319789	HepG2	liver:	n/a	chrX:110319615-110319626
29	CEBPB	chrX:110249443-110249707	K562	blood:	n/a	n/a
30	CEBPB	chrX:110339233-110339526	H1-hESC	embryonic stem cell:	n/a	n/a
31	CEBPB	chrX:110319464-110319770	A549	lung:	n/a	chrX:110319615-110319626
32	CEBPB	chrX:110353589-110353921	IMR90	lung:	n/a	chrX:110353752-110353763 chrX:110353821-110353833
33	CEBPB	chrX:110263534-110263867	HepG2	liver:	n/a	chrX:110263706-110263717
34	CEBPB	chrX:110249413-110249630	Hela-S3	cervix:	n/a	n/a
35	CEBPB	chrX:110284262-110284517	HepG2	liver:	n/a	n/a
36	CEBPB	chrX:110263611-110263895	K562	blood:	n/a	chrX:110263706-110263717
37	CEBPB	chrX:110251285-110251497	IMR90	lung:	n/a	n/a
38	CEBPB	chrX:110319472-110319758	K562	blood:	n/a	chrX:110319615-110319626
39	CEBPB	chrX:110242506-110242605	K562	blood:	n/a	chrX:110242565-110242574 chrX:110242563-110242576 chrX:110242565-110242576 chrX:110242565-110242574 chrX:110242563-110242574 chrX:110242565-110242574 chrX:110242565-110242574
40	CEBPB	chrX:110263532-110263873	A549	lung:	n/a	chrX:110263706-110263717
41	CEBPB	chrX:110263586-110263791	K562	blood:	n/a	chrX:110263706-110263717
42	CEBPB	chrX:110289617-110289878	IMR90	lung:	n/a	n/a
43	CEBPB	chrX:110289642-110289862	A549	lung:	n/a	n/a
44	CEBPB	chrX:110339191-110339529	HepG2	liver:	n/a	n/a
45	CEBPB	chrX:110353583-110353957	HepG2	liver:	n/a	chrX:110353752-110353763 chrX:110353821-110353833
46	CEBPB	chrX:110284236-110284640	A549	lung:	n/a	n/a
47	CEBPB	chrX:110340225-110340456	HepG2	liver:	n/a	chrX:110340278-110340289 chrX:110340277-110340290 chrX:110340277-110340290
48	CEBPB	chrX:110290825-110291068	IMR90	lung:	n/a	n/a
49	CEBPB	chrX:110263531-110263885	IMR90	lung:	n/a	chrX:110263706-110263717
50	CEBPB	chrX:110353617-110353884	K562	blood:	n/a	chrX:110353752-110353763 chrX:110353821-110353833

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chrX:110339313-110339363	MCF-7	breast:	n/a
2	chrX:110339313-110339363	MCF-7	breast:	n/a
3	chrX:110187179-110187229	HRCEpiC	kidney:	n/a
4	chrX:110342214-110342264	Hela-S3	cervix:	n/a
5	chrX:110339051-110339101	T-47D	breast:	n/a
6	chrX:110339051-110339101	GM19239	blood:	n/a
7	chrX:110187233-110187283	HepG2	liver:	n/a
8	chrX:110339837-110339887	IMR90	lung:	fetal
9	chrX:110339051-110339101	A549	lung:	n/a
10	chrX:110339005-110339055	NH-A	brain:	n/a
11	chrX:110187501-110187551	U87	brain:	n/a
12	chrX:110187465-110187515	ECC-1	luminal epithelium:	n/a
13	chrX:110187465-110187515	MCF10A-Er-Src	breast:	n/a
14	chrX:110186893-110186943	PANC-1	pancreas:	n/a
15	chrX:110186893-110186943	ProgFib	skin:	n/a
16	chrX:110339862-110339912	GM06990	blood:	n/a
17	chrX:110187465-110187515	SK-N-MC	brain:	n/a
18	chrX:110339654-110339704	HL-60	blood:	n/a
19	chrX:110188397-110188447	BE2_C	brain:	n/a
20	chrX:110339837-110339887	PFSK-1	brain:	n/a
21	chrX:110187501-110187551	NT2-D1	testis:	n/a
22	chrX:110188323-110188373	U87	brain:	n/a
23	chrX:110187233-110187283	GM12892	blood:	n/a
24	chrX:110339313-110339363	GM12878	blood:	n/a
25	chrX:110339005-110339055	AG04450	lung:	fetal
26	chrX:110187179-110187229	NB4	blood:	n/a
27	chrX:110339051-110339101	MCF-7	breast:	n/a
28	chrX:110187421-110187471	PFSK-1	brain:	n/a
29	chrX:110339313-110339363	GM12891	blood:	n/a
30	chrX:110339372-110339422	HCM	heart:	n/a
31	chrX:110342214-110342264	BE2_C	brain:	n/a
32	chrX:110339365-110339415	A549	lung:	n/a
33	chrX:110187600-110187650	GM12892	blood:	n/a
34	chrX:110187555-110187605	AG09309	skin:	n/a
35	chrX:110187179-110187229	AoSMC	blood vessel:	n/a
36	chrX:110339862-110339912	HNPCEpiC	eye:	n/a
37	chrX:110188397-110188447	AG04450	lung:	fetal
38	chrX:110339372-110339422	Caco-2	colon:	n/a
39	chrX:110187465-110187515	AG04450	lung:	fetal
40	chrX:110339485-110339535	SAEC	small airway:	n/a
41	chrX:110187600-110187650	MCF-7	breast:	n/a
42	chrX:110339654-110339704	SK-N-SH	brain:	n/a
43	chrX:110339485-110339535	K562	blood:	n/a
44	chrX:110339032-110339082	SAEC	small airway:	n/a
45	chrX:110188323-110188373	IMR90	lung:	fetal
46	chrX:110339485-110339535	Hela-S3	cervix:	n/a
47	chrX:110187600-110187650	ProgFib	skin:	n/a
48	chrX:110339051-110339101	HEK293	kidney:	embryo
49	chrX:110186893-110186943	Hepatocyte	liver:	n/a
50	chrX:110339365-110339415	HMEC	breast:	n/a

No.	Distal block	Cell Line	Cell type
1	chrX:110096476..110097281-chrX:110343043..110343676,2	MCF-7	breast:
2	chrX:110249821..110252396-chrX:110256754..110259778,3	K562	blood:
3	chrX:110206329..110208315-chrX:110208664..110210255,2	K562	blood:
4	chrX:110196645..110198633-chrX:110202111..110203824,2	K562	blood:
5	chrX:110326362..110328069-chrX:110331254..110332905,2	K562	blood:
6	chrX:110249821..110252396-chrX:110256754..110259778,3	K562	blood:
7	chrX:110342959..110344460-chrX:110514484..110517120,2	K562	blood:
8	chrX:110349889..110351867-chrX:110354398..110356796,2	MCF-7	breast:
9	chrX:110249821..110252612-chrX:110256754..110259778,3	K562	blood:
10	chrX:110206329..110208315-chrX:110208664..110210255,2	K562	blood:
11	chrX:110096399..110097420-chrX:110342866..110344069,8	MCF-7	breast:
12	chrX:110326362..110328069-chrX:110331254..110332905,2	K562	blood:
13	chrX:110235520..110236090-chrX:110690097..110690889,2	MCF-7	breast:
14	chrX:110249821..110252612-chrX:110256754..110259778,3	K562	blood:
15	chrX:110196645..110198633-chrX:110202111..110203824,2	K562	blood:
16	chrX:110349889..110351867-chrX:110354398..110356796,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ALG13-8	chrX:110339771-110339965	NONHSAT138173
2	lnc-ALG13-8	chrX:110339553-110339643	NONHSAT138173
3	lnc-RGAG1-4	chrX:110228634-110230907	NONHSAT138172
4	lnc-ALG13-8	chrX:110340618-110340684	NONHSAT138173
5	lnc-ALG13-8	chrX:110340803-110340912	NONHSAT138173
6	lnc-ALG13-8	chrX:110341768-110342014	NONHSAT138173
7	lnc-RGAG1-5	chrX:110254149-110259085	ucscGeneNc_uc004epb_2

Variant related genes	Relation type
PAK3	TF binding region
PAK3	CpG island

Extended variants
information (count: 1953 )
Associated
traits (count: 48 )

Variant overlapped rSNPs/rCNVs (count:1953 , 50 per page) page: 1 2 3 4 5 6 7 ... 40

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs148697707	chrX:110184876-110184877	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs369316148	chrX:110184895-110184896	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs187492206	chrX:110184943-110184944	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs143453459	chrX:110185155-110185156	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs375257081	chrX:110185159-110185160	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs146064594	chrX:110185170-110185171	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs140003140	chrX:110185554-110185555	Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs549790744	chrX:110185577-110185578	Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs190479883	chrX:110185637-110185638	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs201250045	chrX:110185706-110185707	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs143695399	chrX:110185796-110185797	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs548621612	chrX:110185901-110185902	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs528432572	chrX:110186028-110186029	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs12558090	chrX:110186080-110186081	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs367885624	chrX:110186111-110186112	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs1556803	chrX:110186221-110186222	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs534040225	chrX:110186257-110186258	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs546546496	chrX:110186332-110186333	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs183057163	chrX:110186434-110186435	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs374672610	chrX:110186464-110186465	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs547919304	chrX:110186557-110186558	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs140492138	chrX:110186587-110186588	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs1933118	chrX:110186592-110186593	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs556418550	chrX:110186647-110186648	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs145328987	chrX:110186661-110186662	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs571443780	chrX:110186839-110186840	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs73542057	chrX:110187026-110187027	Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs142656245	chrX:110187028-110187029	Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs201152205	chrX:110187122-110187123	Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs72619709	chrX:110187124-110187125	Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs386417401	chrX:110187126-110187127	Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs3033531	chrX:110187131-110187132	Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs146895589	chrX:110187182-110187183	Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs192740262	chrX:110187404-110187405	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs368362056	chrX:110187774-110187775	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs184416056	chrX:110187934-110187935	Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs187683313	chrX:110187984-110187985	Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs35822702	chrX:110188113-110188114	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs193248170	chrX:110188164-110188165	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs184833663	chrX:110188240-110188241	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs72619710	chrX:110188254-110188255	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs189348282	chrX:110188256-110188257	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs1538180	chrX:110188352-110188353	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs181373301	chrX:110188397-110188398	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs374615925	chrX:110188449-110188450	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs184410360	chrX:110188555-110188556	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs1538181	chrX:110188612-110188613	Bivalent/Poised TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs148018789	chrX:110188710-110188711	Bivalent/Poised TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs141670221	chrX:110188711-110188712	Bivalent/Poised TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs189704715	chrX:110188750-110188751	Bivalent/Poised TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:48)

Disease	PMID	Source
Neuroblastoma	18923191	CNVD
Burkitt''s lymphoma	20823134	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Astrocytoma	17387387	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Metanephric adenoma	20802469	CNVD
Medulloblastoma	21979893	CNVD
Schizophrenia	23904455	CNVD
Olfactory neuroblastoma	18408657	CNVD
infertile	22614455	CNVD
Autism	22495311	CNVD
Cancer	20581869	CNVD
Multiple myeloma	20724749	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
lymphocytic leukemia	21291569	CNVD
Testicular germ cell tumor	18059402	CNVD
Testicular cancer	18059402	CNVD
Seminomas	18059402	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Cancer	22429812	CNVD
Cancer	16751803	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Multiple myeloma	17550852	CNVD
Cerebellar hypoplasia	21569638	CNVD
X-linked lissencephaly	21569638	CNVD
Pelizaeus-Merzbacher disease	18923514	CNVD
Pelizaeus-Merzbacher disease	22241247	CNVD
Cervical cancer	21062161	CNVD
Myxofibrosarcoma	16751306	CNVD
Pelizaeus-Merzbacher disease	22470819	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Astrocytoma	22246337	CNVD
Hirschsprung''s Disease	21712996	CNVD
X-linked lissencephaly	21572526	CNVD
Breast cancer	21364760	CNVD
Pancreatic cancer	17952125	CNVD
Sertoli-cell only syndrome	20877625	CNVD
Oligozoospermia	20877625	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:952 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chrX:110182600-110187600	Weak transcription	Gastric	stomach
2	chrX:110182600-110188600	Weak transcription	Stomach Mucosa	stomach
3	chrX:110183200-110187200	Weak transcription	Pancreas	Pancrea
4	chrX:110184800-110186000	Enhancers	HMEC	breast
5	chrX:110185400-110185800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
6	chrX:110185800-110186600	Enhancers	Breast Myoepithelial Primary Cells	Breast
7	chrX:110186000-110187400	Bivalent Enhancer	HMEC	breast
8	chrX:110186600-110187200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
9	chrX:110186800-110187000	Enhancers	Brain Germinal Matrix	brain
10	chrX:110186800-110187200	Enhancers	Brain Angular Gyrus	brain
11	chrX:110187000-110187400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
12	chrX:110187000-110188400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
13	chrX:110187000-110188600	Bivalent/Poised TSS	Fetal Kidney	kidney
14	chrX:110187000-110188800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
15	chrX:110187000-110189800	Bivalent/Poised TSS	Fetal Brain Female	brain
16	chrX:110187000-110190200	Active TSS	Brain Germinal Matrix	brain
17	chrX:110187200-110187400	Flanking Bivalent TSS/Enh	H9 Cell Line	embryonic stem cell
18	chrX:110187200-110187400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
19	chrX:110187200-110187400	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
20	chrX:110187200-110187400	Enhancers	Pancreas	Pancrea
21	chrX:110187200-110188200	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
22	chrX:110187200-110188400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
23	chrX:110187200-110188400	Bivalent/Poised TSS	Breast Myoepithelial Primary Cells	Breast
24	chrX:110187200-110188600	Active TSS	NH-A	brain
25	chrX:110187200-110188800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
26	chrX:110187200-110188800	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
27	chrX:110187200-110189000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
28	chrX:110187200-110189000	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
29	chrX:110187400-110187600	Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chrX:110187400-110187600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chrX:110187400-110187600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chrX:110187400-110187600	Active TSS	Brain Hippocampus Middle	brain
33	chrX:110187400-110187600	Bivalent/Poised TSS	HMEC	breast
34	chrX:110187400-110188000	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
35	chrX:110187400-110188000	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
36	chrX:110187400-110188000	Active TSS	Esophagus	oesophagus
37	chrX:110187400-110188000	Bivalent Enhancer	Placenta	Placenta
38	chrX:110187400-110188200	Active TSS	Cortex derived primary cultured neurospheres	brain
39	chrX:110187400-110188200	Bivalent/Poised TSS	Fetal Muscle Leg	muscle
40	chrX:110187400-110188400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
41	chrX:110187400-110188400	Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chrX:110187400-110188400	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
43	chrX:110187400-110188400	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
44	chrX:110187400-110188400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
45	chrX:110187400-110188400	Bivalent/Poised TSS	Fetal Adrenal Gland	Adrenal Gland
46	chrX:110187400-110188400	Active TSS	Pancreatic Islets	Pancreatic Islet
47	chrX:110187400-110188400	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
48	chrX:110187400-110188400	Bivalent/Poised TSS	Fetal Stomach	stomach
49	chrX:110187400-110188600	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
50	chrX:110187400-110188600	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links